Astrana Health Q2 revenue $972.5M (+49% YoY); raises 2026 adjusted EBITDA guidance

Astrana Health, Inc.

Q2 revenue $972.5M (+49% YoY); net income attributable $19.7M (+109%); adjusted EBITDA $68.9M (+43%).
Adjusted diluted EPS $0.80 (+45% YoY); six-month adjusted EPS $1.54 (+59%).
Six-month free cash flow $92.9M; operating cash flow $100.8M.
Management raises 2026 adjusted EBITDA guidance citing strong first-half outperformance.
Care Partners revenue $932.8M (+48% YoY) drives top-line growth.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.